Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Regeneron Pharmaceuticals Inc.

Countdown to close

REGN
/zigman2/quotes/203149337/composite

$

495.34

Change

-11.14 -2.20%

Volume

Volume 513,878

Apr 22, 2021, 3:25 p.m.

Real time quotes

/zigman2/quotes/203149337/composite

Previous close

$ 506.48

$ 495.34

Change

-11.14 -2.20%

Day low

Day high

$495.28

$505.40

Open
Open: 505.40

52 week low

52 week high

$441.00

$664.64

Open

Market cap

$54.26B

Average volume

953,994

P/E ratio

16.17

Rev. per Employee

$931,393

EPS

30.68

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  1. 5 Undervalued Stocks in Biopharma, the Sweet Spot in Healthcare

    5:39 p.m. April 21, 2021

    - Josh Nathan-Kazis

  9. GSK and Vir Submit Covid-19 Drug for FDA Authorization

    9:49 a.m. March 26, 2021

    - Josh Nathan-Kazis

  13. You Can Buy a Tesla With Bitcoin Now

    8:28 a.m. March 24, 2021

  15. Pfizer Will Test a Pill to Kill the Covid-19 Virus

    12:42 p.m. March 23, 2021

    - Bill Alpert

  16. Regeneron Stock Climbs on Positive Covid-19 Antibody Data

    9:17 a.m. March 23, 2021

    - Josh Nathan-Kazis

  17. Regeneron Stock Climbs on Positive Covid-19 Antibody Data

    9:17 a.m. March 23, 2021

    - Josh Nathan-Kazis

  19. These 5 Biopharma Stocks Are Undervalued

    1:48 p.m. March 17, 2021

    - Josh Nathan-Kazis

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Why Regeneron (REGN) Could Beat Earnings Estimates Again

    12:10 p.m. Today

    - Zacks.com

  2. Roche (RHHBY) Q1 Sales Affected by Biosimilars & COVID-19

    2:08 p.m. April 21, 2021

    - Zacks.com

  3. 3 Cheap Cathie Wood Stocks to Buy Right Now

    6:25 a.m. April 21, 2021

    - Motley Fool

  4. Should You Buy Gilead Sciences in April?

    6:15 a.m. April 21, 2021

    - Motley Fool

  5. Will Regeneron's COVID Cocktail Win Be Short-Lived?

    6:10 a.m. April 21, 2021

    - Motley Fool

  9. 3 Cathie Wood Stocks You Can Buy at a Bargain Right Now

    7:00 a.m. April 17, 2021

    - Motley Fool

  10. Could Vir Biotechnology Be a Millionaire Maker Stock?

    6:00 a.m. April 17, 2021

    - Motley Fool

  11. Lilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone

    5:39 p.m. April 16, 2021

    - Peter Loftus

  13. Top Net Payout Yields - April 2021

    2:47 p.m. April 15, 2021

    - Seeking Alpha

  14. Merck hurt by another setback in its battle against COVID-19

    1:39 p.m. April 15, 2021

    - Seeking Alpha

  15. Healthcare Dashboard For April And Focus On IDNA

    1:23 p.m. April 15, 2021

    - Seeking Alpha

  17. Merck Halts Covid-19 Treatment Trial for Hospitalized Patients

    6:46 a.m. April 15, 2021

    - Jared S. Hopkins

  18. Leerink Partners Thinks Regeneron’s Stock is Going to Recover

    9:26 a.m. April 13, 2021

    - SmarterAnalyst

  21. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  18. How to use Regeneron Pharmaceuticals $REGN as a Forecasting Tool

    1:39 a.m. April 17, 2021

    - Stock Traders Daily

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.